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Abstract 
Purpose: To determine the anti-inflammatory activity of curcuminoids in comparison with that of 
eugenol in silico, and to determine the anti-inflammatory activity of wound dressings made from zinc 
oxide powder and liquid turmeric extract with a high curcuminoid content.  
Methods: In silico studies were conducted, using Molegro Virtual Docker program, to predict the anti-
inflammatory potency of curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and 
eugenol against COX-2 receptors. In vivo studies to evaluate anti-inflammatory activity via TNFα 
expression, were carried out using thirty Wistar rats as subjects, divided into two groups: A (sacrificed 
on day 3) and B (sacrificed on day 7). Each group contained three subgroups (n = 5): A1, B1 were 
excised without a dressing as control subgroups; A2, B2 were excised followed by the application of 
zinc oxide with a turmeric extract dressing; and A3, B3 were excised followed by the application of zinc 
oxide with an eugenol dressing.  
Results: The in silico studies confirmed the anti-inflammatory activity of curcumin (-132.905 kcal/mol), 
demethoxycurcumin (-130.265 kcal/mol), bisdemethoxycurcumin (-118.827 kcal/mol) in relation to the 
COX-2 receptor to be greater than that of eugenol (-78.718 kcal/mol). The in vivo studies of TNFα 
expression showed that the levels of activity in the groups without dressings were significantly higher 
than in those with dressing (p<0.05), while the lowest TNFα expression were for zinc oxide with turmeric 
extract dressings. 
Conclusion: The combination of zinc oxide with turmeric liquid extract has a higher anti-inflammatory 
effect than eugenol as demonstrated by both in vivo and in silico studies. This combination can, 
therefore, be used as an alternative to zinc oxide eugenol wound dressings.  
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Injuries resulting from trauma or surgery 
(excision wounds) often occur in the oral cavity. 
The application of wound dressings minimizes 
post-surgical bleeding and infections, while also 
promoting healing by protecting the surface of 
the wound when the patient is eating. Moreover, 
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it reduces the pain caused by contact with the 
tongue and food. The efficacy of wound 
dressings which contain zinc oxide and eugenol 
was first recognized in 1923. However, their use 
is often avoided because of potential allergic 
reactions, for instance, a reddening of the area 
around the application point accompanied by a 
burning sensation, in some patients. Such 
symptoms result from a reaction to zinc oxide 
and eugenol, which produces eugenolate zinc 
and free eugenol. They will increase due to the 
decomposition of eugenolate zinc which causes 
inflammatory reactions, slow healing and tissue 
necrosis [1]. 
 
Alternative dressings that could be applied to 
wounds include zinc oxide-turmeric rhizome 
extract that produces an anti-inflammatory effect 
[2]. Turmeric (Curcuma longa) is one herb 
proven to be safe because of its culinary uses 
and applications as a treatment for several 
diseases [3]. The main active ingredients of 
turmeric rhizome are curcuminoids, flavonoid 
compounds consisting of curcumin, demethoxy-
curcumin, and bisdemethoxycurcumin [4]. 
 
Before in vivo research is conducted, an in silico 
study should be complemented in order to 
assess the anti-inflammatory properties of 
curcuminoids (curcumin, demethoxycurcumin, 
and bisdemethoxycurcumin), as the active 
turmeric extract ingredient, compared to those of 
eugenol. Diclofenac is used as a ligand of the 
anti-inflammatory drug. In silico is a method of 
predicting the chemical properties of a molecular 
physics of drug and identifying the nature of 
compound interaction with receptors, in this case 
COX-2 receptors. In vivo research into the anti-
inflammatory properties of zinc oxide combined 
with turmeric rhizome liquid extract or eugenol 
was conducted in order to detect the presence of 
tumor necrosis factor alpha (TNFα) expression 
as the anti-inflammatory parameter. This study 
aimed to analyze anti-inflammatory curcuminoid 
activity as the main characteristic of turmeric 
extract compared to eugenol with regard to COX-
2 receptors in silico, to evaluate the anti-
inflammatory activity of zinc oxide with turmeric 
extract in wound dressing compared to that of 
eugenol in vivo and, finally, to compare in silico 




In silico study 
 
In silico studies were conducted to assess the 
potency of curcuminoids anti-inflammatory 
activity (curcumin, demethoxycurcumin, and 
bisdemethoxycurcumin) and eugenol against 
COX-2 receptors. An official drug, diclofenac, 
was used for the purposes of comparison [5].  
 
Creation of 2D and 3D moleculare curcumin, 
demethoxycurcumin, bisdemethoxycurcumin, 
eugenol, and diclofenac structures  
 
2D (two-dimensional) curcuminoid derivative 
structures (curcumin, demethoxycurcumin, and 
bisdemethoxycurcumin), eugenol, and diclofenac 
were drawn using a ChemBioOffice Ultra 12.0 
program (Cambridge Soft Co., Cambridge, USA). 
The 2D structure was subsequently converted to 
3D form by means of ChemBio3D 12.0 program 
(Cambridge Soft Co., Cambridge, USA). The 
stereochemical form of the compound was 
observed, with its most stable form being 
regulated through the minimizing of energy by 
the MMFF94 method [6]. It was subsequently 
stored in a SYBYL.mol2 file, enabling it to be 
read by the Molegro Virtual Docker (MVD) 5.5 
program (CLC Bio, Aarhus, Denmark) [7]. The 
computer used was a PC Intel Core I-7, 4GB 
RAM, 32bit Operating System. 
 
Amino acid docking and analysis 
 
Docking drug receptor interaction was conducted 
by means of an MVD program [8], with all drug 
and receptor structures used being in the form of 
3-D (three-dimensional) image. After the 
cyclooxygenase-2 receptor binding to the 
diclofenac ligand (1PXX) had been downloaded 
from the internet at the Research Collaboratory 
for Structural Bioinformatics Protein Data Bank 
(RCSB-PDB) site [9], a cavity on the receptor 
structure to which the ligand was bound or 
interacted was detected in the fifth cavity. The 3-
D structures of the curcumin/ demethoxy-
curcumin/bisdemethoxycurcumin/eugenol in the 
fifth cavity were then connected. The MVD 
program was implemented by aligning a 
molecule which attaches three atoms of the 
compound to three from the same ligand in the 
receptor. The compounds were docked 
automatically onto the receptor (1PXX) by the 
MVD program. The parameters measured in the 
docking process consisted of the energy values 
involved in the form of a MolDock Score with 
three replications. 
 
In vivo studies 
 
The anti-inflammatory activity of a dressing 
containing zinc oxide powder and curcuminoids 
from turmeric rhizome liquid extract was 
compared to one incorporating zinc oxide powder 
and eugenol, by evaluating the expression of 
TNFα from in vivo studies. 
Experimental animals 
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Thirty 12-week old Wistar strain Rattus 
norvegicus weighing between 175 and 275 
grams were purchased from Wistar Farm 
Malang, Indonesia. All were kept individually 
under 12-hour day/12-hour night cycle conditions 
and had access to standard chow pellets and 
water ad libitum. After one week of adaptation, 
they were randomly divided into two groups, 
Group A (sacrificed on day 3) and Group B 
(sacrificed on day 7). The fifteen rats contained 
in each group were further divided into three 
subgroups consisting of five rats: the control 
subgroups which were excised without dressing 
(A1, B1), the first experimental subgroups which 
were excised followed by the application of zinc 
oxide and turmeric liquid extract dressing (A2, 
B2), and the second experimental subgroups 
which were excised followed by the application of 
zinc oxide and eugenol dressing (A3, B3). The 
experimental procedure was approved by the 
Ethical Clearance Section of the Health 
Research Committee, Faculty of Dental Medicine 





Zinc oxide combined with turmeric extract was 
mixed with a stain less steel spatula on a paper 
pad. Turmeric rhizome liquid extract, macerated 
with 96 % ethanol, was purchased from the 
Department of Health of East Java Province 
(Materia Medica, Batu, Indonesia). The extract 
was analyzed by CAMAG Thin Layer 
Chromatography (TLC) – Densitometry (CAMAG, 
Muttenz, Switzerland) Testing Service Unit of the 
Faculty of Pharmacy, Universitas Airlangga, and 
found to consist of 32.34 % curcuminoids. A 
99.8% zinc oxide powder was purchased from 
Merck-Germany, catalog no. 1.08849.0500, 
batch no. K43371349 (Merck KGaA, Darmstadt, 
Germany), while 99.9% eugenol was acquired 
from Merck-Spain, catalog no. 8.18455.0100, 





The previously reported wound excision model 
[10] was followed although with a degree of 
modification. After the administering of a general 
anesthetic with intramuscular ketamine (0.5 
mg/100 g body weight), the vertebral thoracic 
regions were shaved and the skin subsequently 
cleaned with 70% ethanol. An excision wound 
measuring 6 x 6 mm was made with a surgical 
blade No. 15 (Swann Morton, Sheffield, England, 
Lot. 5201411) and the wound was cleaned with 
saline solution (NaCl). 
 
Wound management  
 
The excision wounds of the A1 and B1 
subgroups were left undressed, but covered with 
hypo-allergenic tape (Hypafix, Hamburg, 
Germany, Lot. 44120230). The excision wounds 
of the A2 and B2 subgroup members were 
dressed with a combination of 0.3g zinc oxide 
powder and 0.3g turmeric rhizome liquid extract, 
before being covered with hypo-allergenic tape. 
The excision wounds of theA3 and B3 subgroup 
members were dressed with a combination of 
0.6g zinc oxide powder and 0.2g eugenol, before 
being covered with hypo allergenic tape. 
Turmeric liquid extract contains 32.34 % 
curcuminoids, giving a dressing zinc oxide to 
eugenol ratio of 3:1. Post-wound tissue samples 
were collected by sacrificing the rats on days 3 
(A1, A2, A3 subgroups) and 7 (B1, B2, B3 
subgroups). The rats were euthanized with a 
lethal dose of anesthesia before the post-wound 
areas, consisting of granulation tissues, were 
excised with an additional 5mm on each margin. 
 
Immunohistochemistry evaluation  
 
After the tissue sample had been fixed with 10 % 
neutral buffer formalin (NBF), it was dehydrated 
using a gradient concentration of ethanol, 
washed in xylene, impregnated with paraffin wax, 
embedded in paraffin blocks and cut into 4 μm-
thick section, before being fixed on a microscope 
slide. Subsequent immunohistochemistry 
evaluation adhered to the previously described 
method [2]. The procedural steps were 
completed with minor modifications [11]. A 
solution of 3% H2O2 was added to the samples 
for 30 minutes to inhibit endogenous peroxidase 
activity. The samples were washed in distilled 
water for 10 minutes, incubated in normal goat 
serum in order to block the non-specific binding 
of antibodies. The sections were then incubated 
with a specific monoclonal antibody TNFα 
(54B83):sc-52746, (Santa Cruz Biotechnology, 
Dallas, USA) which was diluted with fetal bovine 
serum (FBS) at a ratio of 1:100 for 1 hour at 
room temperature and washed. The sections 
were subsequently re-incubated with biotinylated 
anti-mouse IgG, re-washed, and re-incubated 
with avidin biotin complex before being re-
washed.  
 
Peroxidase in the sections was detected with a 
di-amino benzidine (DAB) substrate kit. After 
being washed in tap water for 10 minutes and 
dehydrated, the nuclei in the sections were 
stained with hematoxylin and the sections 
mounted with entelan (Merck KGaA, Darmstadt, 
Germany). The immunohistochemistry kit used 
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was the Santa Cruz Biotechnology Kit (Santa 
Cruz Biotechnology, Dallas, USA), while all intra-
step dilution and/or washing was performed 
using phosphate buffer saline (PBS) unless 
otherwise specified. 
 
Statistical analysis  
 
The results were analyzed using SPSS ver. 21 
(IBM, New York, USA). A one-way Analysis of 
Variance (ANOVA) test followed by a least 
significant difference (LSD) test were applied to 
assess statistical differences between the study 




In silico data 
 
An in silico study was conducted to quantity the 
minimum energy of the curcumin, 
demethoxycurcumin, bisdemethoxycurcumin, 
eugenol, and diclofenac molecule ligands which 
were predicted to possess COX-2 inhibiting 
properties. All steps featured the use of ligands 
in 3D form.  
 
A cavity in the receptor structure (1PXX) was 
detected, while a diclofenac ligand was found in 
the fifth cavity, where the curcumin, 
demethoxycurcumin, bisdemethoxycurcumin, 
eugenol ligand (in 3D form) interacted. The 2D 
interaction of curcumin with COX-2 receptor 
resulting in two active methoxy groups, one 
hydrogen bond (Tyr 355) and 11 steric 
interactions (Tyr385, Leu384, 2 Val523, 2 
Ser353, Val116, Val349, 2 Met113, Leu531) can 
be seen in Figure 1. The 2D interaction of 
demethoxycurcumin with the COX-2 receptor 
produced one active methoxy group, one 
hydrogen bond (Tyr355) and nine steric 
interactions (2 Leu384, Val523, 2 Met113, 2 
Val349, 2 Leu531). These can all be seen in 
Figure 2. The 2D interaction of 
bisdemethoxycurcumin with COX-2 receptor 
which produced one hydrogen bond (His90) and 
10 steric interactions (2 Val349, 3 Leu531, 2 
Val523, Ala516, Phe518, Leu352) can be seen in 
Figure 3. The 2D interaction of diclofenac with 
COX-2 receptor had two hydrogen bonds 
(Tyr385, Ser530) and 4 steric interactions 
(Tyr385, Ser353, Tyr355, Met522). The 2D 
interaction of eugenol with the COX-2 receptor 
had only 1 hydrogen bond (Met522) with no 




Figure 1: The 2D form of curcumin interaction with 
COX-2 receptors contains two active methoxy groups 
(red arrow), one hydrogen bond (white arrow) and 11 




Figure 2: The 2D form of demethoxycurcumin 
interaction with COX-2 receptors contains one active 
methoxy group (red arrow), one hydrogen bond (white 




Figure 3: The 2D form interaction of 
bisdemethoxycurcumin with COX-2 receptors contains 
one hydrogen bond (white arrow) and ten steric 




Figure 4: The 2D form of eugenol interaction with 
COX-two receptors contains one hydrogen bond 
(white arrow) 
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A descriptive analysis of three replications of the 
docking process, resulting in mean and standard 
deviation (SD) can be seen in Table 1. 
 
Table 1: MolDock score of ligand against COX-2 
 
Ligand Mean(kcal/mol) ±SD 
Curcumin -132.905c ± 1.989 
Demethoxycurcumin -130.265c ± 5.399 
Bisdemethoxycurcumin -118.827b ± 2.166 
Eugenol -78.718a ± 0,139 
Diclofenac -118.579b ± 0.458 
Values are mean ± SD (n=3); significance at  = 0.05; 
a,b,c the same superscript denotes no differences 
between groups 
 
The lower MolDock score showed that drug 
receptor interaction was more stable and could 
be used to predict the biological activity of the 
drug. The results confirmed the following values: 
curcumin -132,905 kcal/mol, demethoxycurcumin 
-130,265 kca/mol, bisdemethoxycurcumin -
118,827 kcal/mol, and diclofenac -118,579 
kcal/mol. The highest ligand value was eugenol 
at -78,718 kcal/mol. LSD (superscript) test 
results, as shown in Table 2, indicated no 
significant difference in MolDock scores between 
the curcumin with demethoxycurcumin, and 
bisdemethoxycurcumin with diclofenac. 
 
In vivo results 
 
The conducting of a Kolmogorov-Smirnov 
normality test produced a TNFα expression of 
0.876 (p > 0.05) with normal distribution. Levene 
homogeneity of variance significance was 0.504 
(p > 0.05) based on homogeneous data. Normal 
and homogeneous data were required to perform 
a one-way ANOVA test with a 95 % level of 
confidence, significance p = 0.000 (p < 0.05), 
significant difference. This was followed by an 
LSD test to ascertain the difference between 
groups, as seen in superscript of Table 2. 
 
Table 2: TNFα expression in wound excision (n = 5) 
 
Group Mean ± SD    
A1=Excision day 3 (*) 12.40a ±2.074 
A2=Excision + ZnO-T day 3 (*) 8.20b ±1.924 
A3=Excision + ZnO-E day 3 10.20ab  ±1.095 
B1=Excision day 7 (*) 13.60a  ±1.817 
B2=Excision + ZnO-T day 7 (*) 5.20c   ±1.483 
B3=Excision + ZnO-E day 7 7.00bc ±2.646 
Note: *Meizarini et al [2].  a,b,ce Same superscript 
indicates no significant differences between groups (p 
< 0.05),; ZnO-T = zinc oxide mixture with turmeric 
extract; ZnO-E = Zinc oxide mixture with eugenol 
 
There was a decrease in TNFα expression in the 
groups whose wounds were dressed with zinc 
oxide-turmeric liquid extract and zinc oxide-
eugenol dressing on days 3 and 7 (A2, A3, B2, 
B3). However, the lowest expression was found 




MolDock is a molecular docking algorithm with 
prediction algorithm of a cavity. The docking 
scoring function of MolDock is an extension of 
the piecewise linear potential (PLP) including 
hydrogen bond and electrostatic terms. MolDock 
was capable to identify the correct binding mode 
of 87 % of the complexes [12]. The MolDock 
score to be that of curcuminoids consisting of 
curcumin (-132.905kcal/mol), 
demethoxycurcumin (-130.265 kcal/mol) and 
bisdemethoxycurcumin (-118.827 kcal/mol). The 





Figure 5: TNFα expression on days 3 and 7. Excision without dressing (A1, B1), excision with ZnO-T (zinc oxide 
with turmeric extract) dressing (A2, B2), and excision with ZnO-E (zinc oxide with eugenol) dressing (A3, B3). 
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minimum energy of the ligand in relation to the 
protein target.  
 
A strong predictor of potent anti-inflammatory of 
curcuminoids activity is curcumin. This is due to 
its chemical structure which incorporates two 
methoxy active groups (OCH3) capable of 
binding the receptor via steric interactions 
(Tyr385, Leu531), besides the other nine steric 
interactions. While demethoxycurcumin has only 
one methoxy active group, it can bind two2 steric 
interactions (Val349, Leu531) with one hydrogen 
bond and the seven other steric interactions. 
Bisdemethoxycurcumin has no methoxy active 
group, but has one hydrogen bond and ten steric 
interactions. The presence of methoxy active 
groups and the number of steric interactions will 
lead to more extensive interaction with COX-2 
receptors. The lower the minimum energy 
required for ligand-receptor interaction, the 
stronger the interaction affinity between curcumin 
and COX-2. Diclofenac, an official anti-
inflammatory drug, has two hydrogen bonds and 
four steric interactions (MolDock score value = -
118,579 kcal/mol) which are higher than 
curcuminoids. Therefore, it has lower anti 
inflammatory potential. The MolDock scores for 
eugenol were highest, due to its only having one 
hydrogen bond without steric interactions. The 
results of the in silico study confirmed the 
predictive anti-inflammatory activity of 
curcuminoids (curcumin, demethoxycurcumin, 
bisdemethoxycurcumin) on the COX-2 receptor, 
which was greater than that of eugenol. 
 
The results of in vivo research showed that TNFα 
expression increased significantly in the control 
groups (day 3 (A1) and day 7 (B1)), which were 
subjected to excision without dressing, when 
compared to the experimental groups (B2, B3). 
This indicates the condition of control group on 
day 7 to still be in the inflammatory phase due to 
NF-κB releasing TNFα as a pro-inflammatory 
cytokine [2]. The A3 and B3 groups which were 
treated with a zinc oxide and eugenol dressing 
showed a lower expression of TNFα than the 
control group. The study of the group treated with 
zinc oxide with turmeric rhizome liquid extract 
showed a TNFα expression lower than that of the 
other groups on day 3 (A3) which decreased 
further on day 7 (B3), indicating that the 
inflammatory process had subsided.. This proved 
that the curcuminoids from zinc oxide dressing 
with turmeric extract effectively counteract 
oxidant and free radicals which are detached 
from HSP 70 due to excision trauma [13]. These 
results are consistent with studies showing an 
increase in macrophage phagocyte activity in 
animal subjects given curcumin. The action of 
curcumin on macrophages is explained by the 
increase in free oxide capture capacity under 
non-inflammatory conditions [14]. The effect of 
using topical curcumin in treating wounds in the 
inflammatory phase can inhibit the transcription 
activity of NF-κB. This, decreases the production 
of TNFα and IL-1 cytokines, which would further 
reduce the inflammatory activity [15]. Ramsewak 
et al also highlighted that the liquid extract of 
turmeric rhizomes, produced by macerating them 
with ethanol, performed a number of biological 
activities including antibacterial, antioxidant and 
anti-inflammatory [16]. 
 
The in silico results predicted the anti-
inflammatory activity of curcuminoids (curcumin, 
demethoxycurcumin, bisdemethoxycurcumin) 
against the COX-2 receptor to be greater than 
that of eugenol. The results of this in silico study 
were consistent with the results of in vivo 
research which found the expression of 
proinflammatory TNFα, an inflammatory 
cytokine, in the group treated with zinc oxide and 
turmeric liquid extract on day 3 was equivalent 
with the group treated with zinc oxide and 
eugenol on day 7. The group treated with zinc 
oxide and eugenol to be higher than the group 
treated with zinc oxide and turmeric rhizome 
liquid extract. Thus, turmeric liquid extract 
containing curcuminoids produces greater anti-




A combination of zinc oxide and rhizome extract 
of turmeric can produce higher anti-inflammation 
effect and is shown by in vivo studies to be more 
effective than eugenol. These results are 
supported by in silico studies which predict that 
the potential anti-inflammatory effect of 
curcuminoids (curcumin, demethoxycurcumin, 
bisdemethoxycurcumin) will be higher than that 
of eugenol. This suggests that the combination of 
zinc oxide powder and turmeric liquid extract has 
the potential to be used as an alternative to zinc 
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